"metastatic breast cancer" trang 5 - tải miễn phí từ tailieunhanh
Rare subclonal sequencing of breast cancers indicates putative metastatic driver mutations are predominately acquired after dissemination

Rare subclonal sequencing of breast cancers indicates putative metastatic driver mutations are predominately acquired after dissemination
19    16    1
Triple negative breast cancer and platinumbased systemic treatment: A meta-analysis and systematic review

Triple negative breast cancer and platinumbased systemic treatment: A meta-analysis and systematic review
9    88    0
Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: Results of the prospective observational EvAluate-TM study

Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: Results of the prospective observational EvAluate-TM study
9    86    0
Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways

Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways
13    40    0
PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes

PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes
10    84    0
Trends in incidence, mortality and survival in women with breast cancer from 1985 to 2012 in Granada, Spain: A population-based study

Trends in incidence, mortality and survival in women with breast cancer from 1985 to 2012 in Granada, Spain: A population-based study
14    75    0
Prevalence of ESR1 E380Q mutation in tumor tissue and plasma from Japanese breast cancer patients

Prevalence of ESR1 E380Q mutation in tumor tissue and plasma from Japanese breast cancer patients
9    56    1
Identification of predictive markers of the therapeutic effect of eribulin chemotherapy for locally advanced or metastatic breast cancer

Identification of predictive markers of the therapeutic effect of eribulin chemotherapy for locally advanced or metastatic breast cancer
10    74    1
Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: A case report

Trastuzumab resumption after extremely severe cardiotoxicity in metastatic breast cancer patient: A case report
5    26    1
Burden of early, advanced and metastatic breast cancer in The Netherlands

Burden of early, advanced and metastatic breast cancer in The Netherlands
11    43    1
Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer

Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer
11    66    1
Histologic subtyping affecting outcome of triple negative breast cancer: A large Sardinian population-based analysis

Histologic subtyping affecting outcome of triple negative breast cancer: A large Sardinian population-based analysis
14    44    1
The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases

The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases
13    45    1
The Yin/Yan of CCL2: A minor role in neutrophil anti-tumor activity in vitro but a major role on the outgrowth of metastatic breast cancer lesions in the lung in vivo

The Yin/Yan of CCL2: A minor role in neutrophil anti-tumor activity in vitro but a major role on the outgrowth of metastatic breast cancer lesions in the lung in vivo
15    55    1
An 8-gene mRNA expression profile in circulating tumor cells predicts response to aromatase inhibitors in metastatic breast cancer patients

An 8-gene mRNA expression profile in circulating tumor cells predicts response to aromatase inhibitors in metastatic breast cancer patients
9    29    1
Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu– positive advanced breast cancer: Results of the CECOG LaVie trial

Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu– positive advanced breast cancer: Results of the CECOG LaVie trial
7    73    1
Meningeal carcinomatosis underdiagnosis and overestimation: Incidence in a large consecutive and unselected population of breast cancer patients

Meningeal carcinomatosis underdiagnosis and overestimation: Incidence in a large consecutive and unselected population of breast cancer patients
8    64    1
Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates breast cancer cell metastatic behaviors through inhibition of plasminogen activation and extracellular proteolysis

Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates breast cancer cell metastatic behaviors through inhibition of plasminogen activation and extracellular proteolysis
12    39    1
Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients

Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients
14    65    1
Tumour biology, metastatic sites and taxanes sensitivity as determinants of eribulin mesylate efficacy in breast cancer: Results from the ERIBEX retrospective, international, multicenter study

Tumour biology, metastatic sites and taxanes sensitivity as determinants of eribulin mesylate efficacy in breast cancer: Results from the ERIBEX retrospective, international, multicenter study
9    46    1